Biotech d-Conference: Biotechnology and Life Sciences Global Venture Congress 2006 New York SAEC Ventures

2006 Delegates Experience
__________________________________________________________

Sent: Sunday, September 17, 2006 3:35 PM

I want to thank you for all you efforts to organize a very successful Global Venture Congress this past week.

I also want to truly thank Gyan Parida. He was a most graceful host with kind, welcoming word to for all. I do not have an email for Gyan, so I hope you can forward this email to him.

I was very impressed by the GVC event. To put this is perspective, I had just come from presenting at the DowJones VentureWire conference in San Francisco. I had anticipated that the DowJones event would be more valuable to --------, as I had little previous information about GVC. I was wrong. Overall, the GVC had much better panels and attracted a much larger number of leading venture capital firms and industry players.

At GVC I was able to generate contacts and re-connect with many individuals who can help --------- . As a new therapeutics area, we have the dual challenge to explain our new products and how we can create a new market. The GVC event helped by providing a forum to a quality audience.

As I look at the Bio Congress Conference Evaluation Form, I give a "strongly agree" to each of the 8 questions. For future events, it would be useful to have a short synopsis of the presenting companies and bio of the presenter. It was a nice feature to have the VC's give candid comments on the company presentations.

Thanks again, and I look forward to speaking with you soon.

Best regards,
------------- Ph.D.
CEO

_______________________________________

Sent: Monday, September 18, 2006 9:34 PM

"I have enjoyed participating in the panel discussions. We can all learn from the insights and approaches of our colleagues"

-Seth Orlow MD PhD
Venture Partner
Easton Hunt Capital Partners

_______________________________________

Sent: Monday, September 18, 2006 7:09 PM

The conference represented two of the most productive days of my professional career. I established four key contacts, and had numerous engaging conversations during the meals, reception, and unhurried breaks.
Thanks so much.
Will Driscoll
Vaccine For All LLC

_______________________________________

Sent: Tuesday, September 19, 2006 12:31 AM

"As a panel moderator, I learned a lot from my fellow panelists, all of whom represented venture funds and investment banks that I would class among the leading financial firms in the world with core compentencies in biotech and life sciences. To get open, informal, interactive access to these leaders of the biotech/life sciences investment community is a
rare opportunity."

Dan Burstein
Managing Partner
Millennium Technology Ventures, L.P.

_______________________________________

Sent: Monday, September 18, 2006 5:26 PM

I have attended the conference for the past three years, I believe since it's inception.
I find the keynote address to be generally very stimulating. It also offers the opportunity
to tap in to the experience of many seasoned professionals in a completely unbiased
and non-competitive environment. I recommend the conference to any new or veteran biotechnology professional. I found my current post by contacts I made at the BioCongress.... be well.
[p]
-----------------------------------------------------
Pericles John Lantz II, MD MMM
Chief Operating Officer
HealthPia America

_______________________________________

Sent: Monday, September 18, 2006 8:24 PM

The Global Congress 2006 was a very well planned event.

The panel speakers were an excellent representation, and attendees were fortunate to experience the discussions as well as the professionalism of the conference staff. The food and location was also excellent.

Thank you so much!
joya comeaux
Biomedical Technology Transfer International (BTTI)

_______________________________________

Sent: Tuesday, September 19, 2006 10:08 AM

An exciting forum with effective information transferal. Not to be missed.

AJ
Dr. Andrew Jay
Managing Partner
Medical Solutions Fund
Siemens Venture Capital

_______________________________________